Firms like Indian Immunologicals (IIL) and Wockhardt are in talks for manufacturing tie-ups with US vaccine major Moderna for its mRNA platform-based vaccine, sources said. “There are two specific steps in vaccine manufacturing. One is making the drug substance, and another is filling the drug substance in vials.
If a foreign player supplies the drug substance, then several Indian players have fill-finish capabilities to make the final product. This would typically enhance the vaccine maker’s capacity and reach in this market,” said a person close to the development. …
- Oxford preparing COVID-19 vaccine versions to fight virus variants: Report [https://www.udayavani.com/english-news/oxford-preparing-covid-19-vaccine-versions-to-fight-virus-variants-report]